RECODE-DCM Newsletter Highlights (October 2024)

Welcome to the RECODE-DCM network!

Myelopathy.org is leading the fight for people with Degenerative Cervical Myelopathy (DCM), to build a world where people can live their lives free of the life-limiting impact of DCM and have a healthy, active, and independent future. The RECODE-DCM network is the research arm of Myelopathy.org.

The RECODE-DCM Incubators: How Are They Getting On?

The charity has ambitious goals to improve the outcome of patients with myelopathy. There are three main ways that the charity works to achieve this: (1) increased recognition and awareness of DCM (2) Offering support to people with DCM (3) learning more about the disease through increased research – this is where RECODE-DCM targets. 

Peri-operative incubator: The team in the peri-operative incubator, which is chaired by David Anderson (University of Sydney, Australia) has recently been involved in some exciting projects to aiming to improve the outcomes of surgery for patients.

Led by Caroline Treanor (Beaumont Hospital, Ireland), the team is currently working with the Enhanced Recovery After Surgery (ERAS) Society to develop a guideline for the surgical management of DCM. The group has been performing a systematic review to look in the literature for evidence about which parts of surgery are important for the outcome of patients. In addition, expert opinions from around the world and from many different disciplines have been sought. These will be used to create a guideline for DCM surgery to help improve surgery for patients across the world!

Diagnostic incubator: The chair of this incubator, Michael Fehlings (Toronto Western Hospital, Canada) and the team have begun some exciting work developing diagnostic criteria for DCM, which will help clinicians to be able to spot DCM more accurately allowing for faster diagnoses and better outcomes.

The incubator team is working with AO spine, an international community of spine surgeons, to distribute a survey to its members. The incubator is also beginning to establish a central cohort of experts from professions including spine surgeons, neurologists, physiotherapists and Primary Care. These experts will finalise and weight the criteria once after the survey results have been collated. 

Natural History incubator: The natural history team has been working to understand more about the  course of the disease throughout time. This will allow us to predict which people with mild DCM will deteriorate and therefore pre-emptive surgery. Furthermore, we will be able to target people who are at risk of developing DCM and offer treatment or advice to prevent them getting DCM in the first place. 

Thank You for Your Interest in Our Network’s Scientific and Clinical Initiatives

Please share this newsletter with your friends and colleagues, and encourage them to join our network.

If you have any questions, comments or suggestions, please email our project manager, Jay Wardropper, at jay@myelopathy.org. 

For any further enquiries, please email info@myelopathy.org.

Best wishes,

Ben Davies and the RECODE-DCM Team

#MyelopathyMatters